Xbrane Biopharma has announced that Susanna Helgesen, CFO of Xbrane Biopharma, and the company have jointly decided to go their separate ways as there will be a change of the CFO role.
Susanna will continue as CFO until a successor is appointed and a date for Susanna’s last day as CFO will be communicated once it has been decided.
The company has initiated a process to search for a replacement who will hold a combined CFO and IR role.
Susanna Helgesen has been CFO of Xbrane since May 2017.
“I want to thank Susanna for her strong efforts as CFO for Xbrane. She has been critical in our growth journey so far and especially in the process of getting on Nasdaq’s main list. I want to wish her all the best in her future career”, says Martin Åmark, CEO.